Summary
- ATXA was included in the second batch of 2024 Guangdong high-tech enterprise filings.
- The public article connects the recognition with ATXA's R&D system, intellectual property, technology transfer and high-tech product development.
- ATXA says it will continue exploring starch and plant-based capsule films, flavor variety and storage conditions.
The public filing for the second batch of 2024 Guangdong high-tech enterprises was released on November 28, 2024. The article describes a review covering intellectual property, technology transfer and R&D organization management.
ATXA is described as a nutrition and health food manufacturer integrating R&D, production and teaching. It continues to invest in R&D, improve formulations and processes, and develop maternal and child softgel applications.
The recognition reflects a stage of progress in technology innovation, intellectual property and high-tech product development. The article says ATXA will continue exploring starch and plant-based capsule films, flavor variety and storage conditions.